SPDR 시리즈 신탁 - State Street SPDR S&P Pharmaceuticals ETF
US ˙ ARCA ˙ US78464A7220

SecurityXPH / SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF
InstitutionCommonwealth Equity Services, Inc
Latest Disclosed Ownership13,632 shares
Latest Disclosed Value $ 580,000
Commonwealth Equity Services, Inc reports 1.41% increase in ownership of XPH / SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF

On February 16, 2018 - Commonwealth Equity Services, Inc filed a 13F-HR/A form disclosing ownership of 13,632 shares of SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF (US:XPH) valued at $580,042 USD as of September 30, 2017. The entity filed a previous 13F-HR/A on February 16, 2018 disclosing 13,442 shares of SPDR Series Trust - State Street SPDR S&P Pharmaceuticals ETF. This represents a change in shares of 1.41% during the quarter. The current value of the position is $777,569 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2018-02-16 2017-09-30 13F/A-1 SPDR SERIES TRUST S&P PHARMAC 78464A722 13,632 190 1.41 580 0.35 0.0035
2017-11-07 2017-09-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 13,631 189 580
2018-02-16 2017-06-30 13F/A-1 SPDR SERIES TRUST S&P PHARMAC 78464A722 13,442 -26,894 -66.67 578 -65.74 0.0037
2017-08-11 2017-06-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 13,442 -26,894 578
2018-02-16 2017-03-31 13F/A-1 SPDR SERIES TRUST S&P PHARMAC 78464A722 40,336 27,548 215.42 1,687 237.40 0.0113
2017-05-15 2017-03-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 40,336 27,548 1,687
2018-02-16 2016-12-31 13F/A-1 SPDR SERIES TRUST S&P PHARMAC 78464A722 12,788 -865 -6.34 500 -17.08 0.0037
2017-02-01 2016-12-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 12,788 -865 500
2016-10-25 2016-09-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 13,653 10 0.07 603 5.79 0.0048
2016-08-04 2016-06-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 13,643 -80 -0.58 570 3.26 0.0048
2016-04-27 2016-03-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 13,723 -399 -2.83 552 -23.65 0.0049
2016-01-19 2015-12-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 14,122 -1,153 -7.55 723 0.84 0.0068
2015-10-27 2015-09-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 15,275 2,944 23.87 717 -53.38 0.0075
2015-07-28 2015-06-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 12,331 118 0.97 1,538 1.92 0.0153
2015-04-28 2015-03-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 12,213 4,748 63.60 1,509 87.22 0.0157
2015-01-13 2014-12-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 7,465 -2,906 -28.02 806 -26.66 0.0090
2014-10-17 2014-09-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 10,371 -114 -1.09 1,099 1.01 0.0134
2014-07-23 2014-06-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 10,485 1,288 14.00 1,088 26.36 0.0132
2014-05-07 2014-03-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 9,197 2,444 36.19 861 44.95 0.0119
2014-02-11 2013-12-31 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 6,753 692 11.42 594 27.47 0.0086
2013-11-04 2013-09-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 6,061 2,012 49.69 466 63.51 0.0076
2013-07-29 2013-06-30 13F SPDR SERIES TRUST S&P PHARMAC 78464A722 4,049 285
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.